Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries
Keywords: تحویل محلی; Controlled drug release; Drug delivery; In-stent restenosis; Intimal hyperplasia; Local delivery; Nanoparticles; Neointima; Protein tyrosine kinase blocker; Restenosis; Smooth muscle cell; Stent; Tyrphostin;